Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Maze Therapeutics (MAZE) Return on Capital Employed (2025)

Maze Therapeutics has reported Return on Capital Employed over the past 1 years, most recently at 0.37% for Q4 2025.

  • Quarterly Return on Capital Employed changed N/A to 0.37% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.37% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.48% for FY2025, N/A changed from the prior year.
  • Return on Capital Employed was 0.37% for Q4 2025 at Maze Therapeutics, up from 0.39% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.19% in Q1 2025 and troughed at 0.42% in Q2 2025.